The positive effect of combining IFN and chemotherapies in pancreatic cancer has also been proven in vivo and in clinical studies, including in combination with gemcitabine, fluorouracil, and cisplatin [40,41]. This evidence concerns the gene IFNA1 and pancreatic neoplasm.